Dyslipidemia Management
There is no content available at this time. Please check again later.
Relevant Content
Lipoprotein(a): An Atherosclerotic Cardiovascular Disease Risk Factor That Can No Longer Be Ignored
Associations of Cardiovascular–Kidney–Metabolic Syndrome With All‐Cause and Cardiovascular Death and the Progression of Cardiovascular–Kidney–Metabolic Syndrome Among Hong Kong Chinese People Over 2 Decades
Alterations in Cardiac and Systemic Metabolism in Heart Failure
Journal of the American Heart Association, Ahead of Print.
Background...
Elevated Endogenous Insulin and Insulin Resistance Are Associated With Progressive Diastolic Dysfunction and Worse Cardiovascular Outcomes
Background...
Circulation: Heart Failure, Ahead of Print.
BACKGROUND:Although diabe...
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials
BACKGROUND:Although diabe...
Extension follow-up studies address long-term questions beyond the parent...
Rheumatologic Disease as a Substrate for HFpEF: Pathophysiological Mechanisms and Clinical Implications
Journal of the American Heart Association, Volume 15, Issue 15, August 4,...
Therapeutic Translation of Epicardial Adipose Tissue Targeting in Heart Failure With Preserved Ejection Fraction: How Far Are We?
Journal of the American Heart Association, Volume 15, Issue 15, August 4,...
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Researchers at Heart
Circulation: Heart Failure, Ahead of Print.
Altered cardiac and syste...
Vacuolar H+-ATPase Preserves Cardiolipin Homeostasis Through the Lysosomal-Mitochondrial Axis to Restrain Cardiac Aging
Altered cardiac and syste...
Circulation, Ahead of Print.
BACKGROUND:Cardiac aging involves progre...
BACKGROUND:Cardiac aging involves progre...